These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

501 related items for PubMed ID: 11048528

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillator for secondary prophylaxis.
    Rolf S, Haverkamp W, Borggrefe M, Breithardt G, Bocker D.
    Europace; 2009 Mar; 11(3):289-96. PubMed ID: 19095687
    [Abstract] [Full Text] [Related]

  • 6. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).
    Bokhari F, Newman D, Greene M, Korley V, Mangat I, Dorian P.
    Circulation; 2004 Jul 13; 110(2):112-6. PubMed ID: 15238454
    [Abstract] [Full Text] [Related]

  • 7. [Prognostic factors after sustained ventricular fibrillation or tachycardia. A multivariate study apropos of 160 cases].
    Fleurant E, Lacroix D, Klug D, Warembourg H, Kacet S, Lekieffre J.
    Arch Mal Coeur Vaiss; 1996 Apr 13; 89(4):435-44. PubMed ID: 8763003
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Prognostic significance of impaired intra-and infra-bundle of His conduction in the heart].
    Pleskot M, Pidrman V, Tilser P, Parízek P, Ettlerová E.
    Cas Lek Cesk; 1996 May 15; 135(10):308-12. PubMed ID: 8697493
    [Abstract] [Full Text] [Related]

  • 10. [Idiopathic ventricular fibrillation: from a collection of clinical cases to a prospective evaluation. The U-CARE Steering Committee. Unexplained Cardiac Arrest Registry of Europe].
    Priori SG, Paganini V, Boccalatte L, Schwartz PJ.
    G Ital Cardiol; 1995 Feb 15; 25(2):149-58. PubMed ID: 7642019
    [Abstract] [Full Text] [Related]

  • 11. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD, Doshi RN, Belott P, Birgersdotter-Green U, Behboodikhah M, Ott P, Glatter KA, Tobias S, Frumin H, Lee BK, Merillat J, Wiener I, Wang S, Grogin H, Chun S, Patrawalla R, Crandall B, Osborn JS, Weiss JP, Lappe DL, Neuman S.
    Circulation; 2007 May 08; 115(18):2382-9. PubMed ID: 17470697
    [Abstract] [Full Text] [Related]

  • 12. Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis.
    Aizer A, Stern EH, Gomes JA, Teirstein AS, Eckart RE, Mehta D.
    Am J Cardiol; 2005 Jul 15; 96(2):276-82. PubMed ID: 16018857
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
    Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, Greene HL, Boczor S, Domanski M, Follmann D, Gent M, Roberts RS.
    Eur Heart J; 2000 Dec 15; 21(24):2071-8. PubMed ID: 11102258
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Sudden cardiac arrest associated with early repolarization.
    Haïssaguerre M, Derval N, Sacher F, Jesel L, Deisenhofer I, de Roy L, Pasquié JL, Nogami A, Babuty D, Yli-Mayry S, De Chillou C, Scanu P, Mabo P, Matsuo S, Probst V, Le Scouarnec S, Defaye P, Schlaepfer J, Rostock T, Lacroix D, Lamaison D, Lavergne T, Aizawa Y, Englund A, Anselme F, O'Neill M, Hocini M, Lim KT, Knecht S, Veenhuyzen GD, Bordachar P, Chauvin M, Jais P, Coureau G, Chene G, Klein GJ, Clémenty J.
    N Engl J Med; 2008 May 08; 358(19):2016-23. PubMed ID: 18463377
    [Abstract] [Full Text] [Related]

  • 17. [Can sudden cardiac death be prevented by treatment with anti-arrhythmia drugs?].
    Zrenner B, Koller B, Rudolph W.
    Herz; 1990 Apr 08; 15(2):90-102. PubMed ID: 2188895
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Response to programmed ventricular stimulation and clinical outcome in cardiac arrest survivors receiving randomised assignment to implantable cardioverter defibrillator or antiarrhythmic drug therapy.
    Cappato R, Boczor S, Kuck KH, CASH Investigators.
    Eur Heart J; 2004 Apr 08; 25(8):642-9. PubMed ID: 15084368
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.